The conglomerate is challenging litigation that claims its flagship weedkiller Roundup causes cancer.

BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term. Bayer also announced pharma ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long ...

Last Friday, the U.S. Supreme Court agreed to hear an appeal filed by Bayer over claims against its Roundup weed killer—news that sent the German company’s stock soaring. There’s good reason for the ...

Investing.com -- Bayer AG (OTC:BAYRY) stock surged 5% on Friday after the U.S. Supreme Court agreed to hear the company’s appeal challenging a $1.25 million Missouri jury verdict related to its ...

Bayer (XTRA:BAYN) has quietly staged a strong rebound over the past month, with shares up around 14% and roughly 34% in the past 3 months, drawing fresh attention to its valuation. See our latest ...

Bayer A.G. stock: contrarian Buy with €35 target. Click for this updated look at BAYZF stock prospects and why I am neutral ...

Investing.com -- Bayer AG shares jumped more than 7% on Monday after the U.S. Supreme Court agreed to hear the German company ...

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

Bayer faces significant risks from litigation and poor M&As, but its current low valuation presents a potential long-term upside, especially post-2025. Despite recent challenges and a dividend cut, ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top ...